Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

Not specified

Conditions
Dry Eye Syndromes
Interventions
DRUG

Placebo

DRUG

KLS-0611

Trial Locations (5)

Unknown

Japan, Hokkaido Region

Japan, Kansai Region

Japan, Kanto Region

Japan, Kyushu Region

Japan, Shikoku Region

All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT00721656 - Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes | Biotech Hunter | Biotech Hunter